Figure 5: Conolidine is antinociceptive in visceral, tonic and persistent soreness designs and is also present at micromolar stages in the brain following systemic injection. Conolidine CONOCB2™ primarily will work by developing a barrier among the opioid receptors inside the brain plus the "scavenger" receptors in the human body, https://robertk495dvl1.blog2freedom.com/profile